创模生物科技(北京)有限公司

CN / En

NEWS

InnoModels Biotechnology: Luminex Technology Innovation

  • Categories:Company news
  • Author:InnoModels Biotechnology
  • Origin:InnoModels Biotechnology
  • Time of issue:2024-01-08 14:42
  • Views:

(Summary description)InnoModels Biotechnology has always been a major player in the life sciences field, and their innovations in Luminex technology have made them stand out from the rest; Luminex technology has a wide range of applications and InnoModels Biotechnology opens up new possibilities for scientists in biomedical research and diagnostic experiments, by providing advanced tools and solutions

InnoModels Biotechnology: Luminex Technology Innovation

(Summary description)InnoModels Biotechnology has always been a major player in the life sciences field, and their innovations in Luminex technology have made them stand out from the rest; Luminex technology has a wide range of applications and InnoModels Biotechnology opens up new possibilities for scientists in biomedical research and diagnostic experiments, by providing advanced tools and solutions

  • Categories:Company news
  • Author:InnoModels Biotechnology
  • Origin:InnoModels Biotechnology
  • Time of issue:2024-01-08 14:42
  • Views:
Information

InnoModels Biotechnology has always been a major player in the life sciences field, and their innovations in Luminex technology have made them stand out from the rest; Luminex technology has a wide range of applications and InnoModels Biotechnology opens up new possibilities for scientists in biomedical research and diagnostic experiments, by providing advanced tools and solutions.
Highly sensitive multi-parameter assays
InnoModels Bio's Luminex technology platform is known for its excellent multi-parameter detection capabilities. By combining flow cytometry and fluorescent microbeads, the technology allows researchers to measure multiple biomarkers simultaneously, thus accelerating the progress of experiments. Whether in protein expression analysis, cell signaling pathway studies or disease diagnosis, this highly sensitive multi-parameter assay provides researchers with more comprehensive data.
Comprehensive range of applications
InnoModels's Luminex range of products covers a wide range of applications from basic research to clinical diagnostics. Their Luminex microbead kits can be used to assay a wide range of molecules such as cytokines, growth factors, cancer markers, etc., providing powerful tools for researchers in different fields. In addition, the company offers customized solutions to meet specific research needs.

 


Data Accuracy and Reliability
InnoModels Biotechnology focuses on the accuracy and reliability of its technology. Their Luminex technology not only provides highly sensitive detection, but also ensures data accuracy and consistency. This has a significant impact on the reliability of results in areas such as drug discovery, clinical trials and biomarker studies.
Customer support and training
As a customer-focused company, InnoModels Biotechnology not only provides advanced technology, but is also committed to providing comprehensive support to their customers. Their dedicated team provides technical support, training and regular updates to ensure that customers are able to take full advantage of Luminex technology.
Continuous Innovation
InnoModels Biotechnology is known for their spirit of continuous innovation. They collaborate with leading organizations and research institutes in the industry to push the boundaries of Luminex technology and continue to introduce newer versions of their products to meet the ever-changing needs of scientific research.
Conclusion
Through their contributions in the field of Luminex technology, InnoModels Biotechnology has provided scientists with powerful tools to drive innovation in biomedical research and clinical diagnostics. Their highly sensitive multi-parameter assays and commitment to customer success make them an indispensable partner in the field of Luminex technology.

Keyword:

In the vast field of oncology and tumor immunopharmacodynamics research, InnoModels Biotechnology (Beijing) Ltd. has become a leader in the industry with its outstanding innovation ability and profound scientific research background. This company, co-founded by scientists from Novo Nordisk China R&D Center, Sino-US Crown and Shanghai Jiao Tong University Institute of Immunology, has been committed to building a stable domestic platform of humanized mouse models of the immune system (HIS) and human tumor xenografts (PDX) since its establishment in 2020, to provide new drug discovery and development companies, translational medicine researchers, and tumor patients with new-generation laboratory animal models for new drug discovery companies, translational medicine researchers, and tumor patients
In recent years, many breakthroughs have been made in the field of biomedical research, among which iHuPBMC-T technology is undoubtedly a shining star. As an innovative platform built by InnoModels Biotechnology (Beijing) Co., Ltd, iHuPBMC-T, with its unique technological advantages, shows great potential in optimizing the reconstruction of human peripheral blood single nucleated cell (PBMC) model and immuno-oncology research.
Recently, InnoModels Biotechnology (Beijing) Co., Ltd. has made a major breakthrough in the field of pharmaceutical technology, and successfully obtained a patent entitled “Method and application for the detection of immune system rebuilding ability of PBMC”. This patent not only adds a new footnote to the R&D strength of InnoModels Biotechnology in the field of biomedicine, but also provides a strong technical support for the promotion of drug research and development and the establishment of humanized experimental animal models
With the rapid development of biotechnology, the in-depth study of the immune system has become the key to new drug discovery, disease diagnosis and treatment. InnoModels Bio-technology (Beijing) Co., Ltd. provides strong support for researchers with its profound scientific background and advanced technology platform. Among them, the ELISpot platform of InnoModels Biotechnology has made a name for itself in the field of immunology research with its high sensitivity and multi-functionality
InnoModels' ADCC platform plays a pivotal role in advancing cancer treatment, and its unique technological advantages and innovative concepts have brought about a far-reaching impact on the field of tumor immunotherapy. The following is a detailed introduction of how the platform promotes the advancement of cancer treatment
In the field of tumor immunotherapy, complement-dependent cytotoxicity (CDC), as an important therapeutic mechanism, is gradually showing its great potential and value. In order to explore this mechanism more deeply, with its profound accumulation in the field of oncology and tumor immunopharmacodynamics CRO services, InnoModels Biotechnology (Beijing) Co., Ltd. has launched the CDC in vitro immune-tumor cell co-culture killing experimental platform, which provides researchers with a powerful and precise tool to help innovate cancer treatment
Previous page
1
2
43
  • Tel 15010000264
  • E-mail limy@imodels.tech
  • Tel 13810723384
  • Top

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL:15010000264        13810723384

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company

北京中因科技有限公司

创模生物科技(北京)有限公司